The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Association of intermediates of bioenergetic pathways and plasma metabolomics with colorectal cancer (CRC): Diagnosis, stage, and survival.
 
Alexandra Gangi
No Relationships to Disclose
 
Daniel Myung Kim
No Relationships to Disclose
 
Francesca Paola Aguirre
No Relationships to Disclose
 
Rocio Alvarez
No Relationships to Disclose
 
Lisa Zhou
No Relationships to Disclose
 
Johanna ten Hoeve
No Relationships to Disclose
 
Yi Jou Liao
No Relationships to Disclose
 
Thomas Graeber
No Relationships to Disclose
 
May Thet Cho
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca/MedImmune; Basilea; Eisai; Exelixis; Genentech/Roche; Ipsen; QED Therapeutics; Seagen; Taiho Pharmaceutical
Speakers' Bureau - Bristol-Myers Squibb/Celgene; Daiichi Sankyo/Astra Zeneca; Helsinn Therapeutics; natera; Pfizer; Taiho Pharmaceutical
Research Funding - AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Immunocore (Inst); incyte (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - AstraZeneca/MedImmune
 
Anser Ali Abbas
No Relationships to Disclose
 
John Davelaar
No Relationships to Disclose
 
Kamya Sankar
No Relationships to Disclose
 
Arsen Osipov
No Relationships to Disclose
 
Andrew Eugene Hendifar
Consulting or Advisory Role - Abbvie; Celgene; Eisai; Faraday Pharmaceuticals; Ipsen; Merus; Novartis; Pancreatic Cancer Action Network; Perthera; Valar Labs; Varian Medical Systems
Research Funding - Ipsen; NGM Biopharmaceuticals (Inst)
Travel, Accommodations, Expenses - Halozyme
Other Relationship - FibroGen
 
Megan Philippa Hitchins
Patents, Royalties, Other Intellectual Property - Methylated DNA markers and assays thereof for use in detecting colorectal cancer. Hitchins M, Haile R, Snyder M, Lee H. Cedars-Sinai MC Tech NP: 65472-891PR0 Provisional Patent Application 3/10/2022.
Travel, Accommodations, Expenses - Epigenomics
 
Jun Gong
Honoraria - Amgen; Astellas Pharma; AVEO; Basilea Pharmaceutical; Bayer; Clinical Congress Consultants; Eisai; Elsevier; EMD Serono; Exelixis; HalioDx; Incyte; Janssen Biotech; Natera; Pfizer/Myovant; QED Therapeutics
Consulting or Advisory Role - Amgen; Astellas Pharma; AVEO; Basilea; Bayer; Clinical Congress Consultants; Eisai; Elsevier; EMD Serono/Merck; Exelixis; HalioDx; Incyte; Janssen Biotech; MJH Life Sciences; Natera; OncLive/MJH Life Sciences; Pfizer/Myovant; QED Therapeutics; Seagen
Patents, Royalties, Other Intellectual Property - PCT/US2021/043961 provisional patent on glutamine and cancer; U.S. Provisional Application Serial No. 63/315,895 on methylated ctDNA markers